LncRNA MST1P2/miR‐133b axis affects the chemoresistance of bladder cancer to cisplatin‐based therapy via Sirt1/p53 signaling

The role of lncRNA XIST/miR-211 axis in modulating the proliferation and apoptosis of osteoarthritis chondrocytes through CXCR4 and MAPK signaling

(2018) Lei Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling

(2018) Shuai Huang et al.   Cell Death & Disease

miR-128 Targets the SIRT1/ROS/DR5 Pathway to Sensitize Colorectal Cancer to TRAIL-Induced Apoptosis

(2018) Bo Lian et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy

(2018) Zhiqiang Sun et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Long noncoding RNA SNHG16 contributes to the development of bladder cancer via regulating miR-98/STAT3/Wnt/β-catenin pathway axis

(2018) Feng Feng et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

MicroRNA-133b suppresses bladder cancer malignancy by targeting TAGLN2-mediated cell cycle

(2018) Feng Zhao et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets

(2017) Cecilia Pop-Bica et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

MicroRNA-133b Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting Sirt1

(2017) Shi Ying et al.   ONCOLOGY RESEARCH

Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression

(2017) Huijuan Jiang et al.   Radiation Oncology

Downregulation of long noncoding RNA TUG1 inhibits proliferation and induces apoptosis through the TUG1/miR-142/ZEB2 axis in bladder cancer cells

(2017) Qian Liu et al.   OncoTargets and Therapy

MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway

(2017) Yan Shu et al.   Oncotarget

Knockdown of SIRT1 Suppresses Bladder Cancer Cell Proliferation and Migration and Induces Cell Cycle Arrest and Antioxidant Response through FOXO3a-Mediated Pathways

(2017) Qingxuan Hu et al.   Biomed Research International

LncRNA MALAT1 Inhibits Apoptosis and Promotes Invasion by Antagonizing miR-125b in Bladder Cancer Cells

(2017) Haibiao Xie et al.   Journal of Cancer

Role of Non-Coding RNAs in the Etiology of Bladder Cancer

(2017) Caterina Gulìa et al.   Genes

Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells

(2016) Jingjing Pan et al.   CANCER LETTERS

SIRT1 promotes epithelial–mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression

(2016) Feifei Cheng et al.   CANCER LETTERS

Chemotherapy for Muscle-Invasive Bladder Cancer

(2016) Patrizia Trenta et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1

(2016) Zhijie Tian et al.   EXPERIMENTAL CELL RESEARCH

TRIMming p53’s anticancer activity

(2016) S Elabd et al.   ONCOGENE

miR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1

(2016) Chuntao Li et al.   Oncotarget

Long noncoding RNAs and Alzheimer's disease

(2016) Qiong Luo et al.   Clinical Interventions in Aging

Emerging concepts on drug resistance in bladder cancer: Implications for future strategies

(2015) Francesco Massari et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

The emerging roles of long noncoding RNAs in common cardiovascular diseases

(2015) Xiaoying Jiang et al.   HYPERTENSION RESEARCH

Long non-coding RNA regulation of reproduction and development

(2015) David H. Taylor et al.   MOLECULAR REPRODUCTION AND DEVELOPMENT

Junk DNA and the long non-coding RNA twist in cancer genetics

(2015) H Ling et al.   ONCOGENE

p53 as a target for the treatment of cancer

(2014) Michael J. Duffy et al.   CANCER TREATMENT REVIEWS

Noncoding RNA in bladder cancer

(2014) Aidan P. Noon et al.   CURRENT OPINION IN UROLOGY

Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling

(2014) Yu Fan et al.   FEBS Journal

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Missing links in cardiology: long non-coding RNAs enter the arena

(2014) Tim Peters et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Resveratrol Differentially Regulates NAMPT and SIRT1 in Hepatocarcinoma Cells and Primary Human Hepatocytes

(2014) Susanne Schuster et al.   PLoS One

Systems biology of cisplatin resistance: past, present and future

(2014) L Galluzzi et al.   Cell Death & Disease

p53 Acetylation: Regulation and Consequences

(2014) Sara Reed et al.   Cancers

Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression

(2013) Ming Luo et al.   CANCER LETTERS

A direct role for small non-coding RNAs in DNA damage response

(2013) Fabrizio d’Adda di Fagagna   TRENDS IN CELL BIOLOGY

Epidemiology and Risk Factors of Urothelial Bladder Cancer

(2012) Maximilian Burger et al.   EUROPEAN UROLOGY

First- and second-line therapy for metastatic urothelial carcinoma of the bladder

(2011) F. A. Yafi et al.   Current Oncology

MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review

(2011) James W.F. Catto et al.   EUROPEAN UROLOGY

What fraction of the human genome is functional?

(2011) C. P. Ponting et al.   GENOME RESEARCH

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer

(2008) Brittney Jung-Hynes et al.   JOURNAL OF BIOLOGICAL CHEMISTRY